Wedbush Securities Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$39.62 - $69.97 $133,123 - $235,099	-3,360 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$62.15 - $90.32 $1,305 - $1,896	-21 Reduced 0.62%	3,360 $278,000
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $148,155 - $288,635	3,381 New	3,381 $259,000
Q1 2020 Apr 17, 2020	SELL	$20.56 - $63.12 $74,139 - $227,610	-3,606 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$28.14 - $73.01 $101,472 - $263,274	3,606 New	3,606 $229,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.